Could a smart pen take the guesswork out of insulin dosing?
Disease control
Completed
This trial tests whether a smart insulin pen called DIA:CONN P8 can help people with type 1, type 2, or pancreatogenic diabetes better control their blood sugar. Participants use the pen for 12 weeks, and the pen automatically calculates bolus insulin doses based on meal informat…
Phase: NA • Sponsor: G2e Co., Ltd • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC